Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Oryzon Genomics (ORY SM)
Watchlist
54
Analysis
Health Care
•
Spain
Oryzon Genomics, SA is a clinical stage biopharmaceutical company that develops epigenetics-based therapeutics.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Oryzon Genomics
•
10 Jan 2024 19:10
•
Issuer-paid
Oryzon Genomics - PORTICO update with planned FDA EoP2
Oryzon Genomics has announced top-line results for the Phase IIb trial (PORTICO) assessing vafidemstat in borderline personality disorder (BPD),...
Edison Investment Research
Follow
261 Views
Share
bullish
•
Oryzon Genomics
•
06 Dec 2023 01:10
•
Issuer-paid
Oryzon Genomics - Grant to bolster ALS pipeline, add funding
Oryzon has announced the receipt of a $0.5m grant from the Amyotrophic Lateral Sclerosis (ALS) Association to support the regulatory clinical...
Edison Investment Research
Follow
272 Views
Share
bullish
•
Oryzon Genomics
•
28 Nov 2023 07:10
•
Issuer-paid
Oryzon Genomics - Key €45m funding to back strategic priorities
Oryzon has secured funding of up to €45m through a revised convertible bond financing agreement with Nice & Green, a Switzerland-based...
Edison Investment Research
Follow
223 Views
Share
bullish
•
Oryzon Genomics
•
07 Nov 2023 01:10
•
Issuer-paid
Oryzon Genomics - Q323 recap ahead of key clinical stages
Oryzon’s Q323 results recapped the clinical progression across its drug development pipeline. The company continues to develop therapies that...
Edison Investment Research
Follow
229 Views
Share
bullish
•
Oryzon Genomics
•
12 Oct 2023 01:10
•
Issuer-paid
Oryzon Genomics - Favorable safety reported in PORTICO Phase II
Oryzon presented a positive update on vafidemstat’s ongoing Phase IIb PORTICO trial in borderline personality disorder (BPD) at the ECNP Congress....
Edison Investment Research
Follow
207 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x